The United Nations announced on Thursday that more than 50 partners are on board to fight neglected tropical diseases, tuberculosis and malaria, and the support is a significant step in the right direction.
"WIPO (World Intellectual Property Organization) Re:Search and its partners are expanding their efforts to drive new medical innovations that will help millions of people around the world," WIPO Director General Francis Gurry said.
Gurry said WIPO Re:Search and its partner BIO Ventures for Global Health (BVGH) connect intellectual property holders with researchers working on new treatments to create complementary partnerships.
BVGH President Jennifer Dent said the commitment and desire to share information and knowledge between partners will help advance research for neglected diseases.
"Through these collaborations, WIPO Re:Search will make a difference in the lives of people living in endemic countries and that is the ultimate goal of consortia members," Dent said.
The U.N. said GlaxoSmithKline, plc., will provide information to India's National Institute of to better understand liver-stage malaria parasites. Sanofi SA and Pfizer, Inc., will work with Saint Louis University to develop anti-diarrheal treatments.
The consortium, launched in 2011, has provided a space for public and private sector researchers to make intellectual property available, thereby helping develop diagnostics, treatments and vaccines.